NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/19/2023
Back to search
Official data from USPTO
TT TUTELA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
09/24/2023
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
03/13/2020
Registration date
09/19/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/19/2023
Last transaction
09/24/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/21/2020
First use in commerce
01/22/2023
Drawing code
3
Owner type
03
Owner location
Vernon Hills, IL
Examiner
JOHNSON, DONALD
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of two "T"'s that intersect with one another and appear as the trunk and limbs of a tree with the tree canopy and two leaves on the right side of the tree encircled, below and to the right of which are the words "Tutela pharmaceuticals".
Holders and representatives
Holders
Tutela Pharmaceuticals Inc.
Representatives
Tutela Pharmaceuticals Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Therapeutic pharmaceutical for the treatment of a variety of human diseases or conditions
Publications
History of USPTO decisions and trademark events.
47 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/19/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/15/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/13/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/24/2023
IUAF
USE AMENDMENT FILED
07/20/2023
EISU
TEAS STATEMENT OF USE RECEIVED
07/20/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/24/2023
EX5G
SOU EXTENSION 5 GRANTED
01/23/2023
EXT5
SOU EXTENSION 5 FILED
01/15/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/19/2022
EX4G
SOU EXTENSION 4 GRANTED
07/16/2022
EXT4
SOU EXTENSION 4 FILED
07/16/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/16/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2022
EX3G
SOU EXTENSION 3 GRANTED
03/02/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/01/2022
NREV
NOTICE OF REVIVAL - E-MAILED
01/25/2022
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
01/25/2022
PETG
PETITION TO REVIVE-GRANTED
01/25/2022
PROA
TEAS PETITION TO REVIVE RECEIVED
01/25/2022
EXT3
SOU EXTENSION 3 FILED
01/21/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/17/2021
EX2G
SOU EXTENSION 2 GRANTED
07/15/2021
EXT2
SOU EXTENSION 2 FILED
07/15/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/15/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/30/2020
EX1G
SOU EXTENSION 1 GRANTED
12/28/2020
EXT1
SOU EXTENSION 1 FILED
12/28/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/28/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/21/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/26/2020
PUBO
PUBLISHED FOR OPPOSITION
05/26/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/06/2020
ALIE
ASSIGNED TO LIE
04/20/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/08/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/08/2020
GNRT
NON-FINAL ACTION E-MAILED
04/08/2020
CNRT
NON-FINAL ACTION WRITTEN
04/08/2020
DOCK
ASSIGNED TO EXAMINER
04/02/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/20/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/19/2020
NWAP
NEW APPLICATION ENTERED
03/17/2020
Continuous trademark protection
Get notified about every new filing that threatens TT TUTELA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.